{"id":"https://openalex.org/W4388084635","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","title":"632 A phase 1/2 open label study of LabVax 3(22)-23 and adjuvant GM-CSF alone or in combination with pembrolizumab in subjects with labyrinthin-positive adenocarcinomas","display_name":"632 A phase 1/2 open label study of LabVax 3(22)-23 and adjuvant GM-CSF alone or in combination with pembrolizumab in subjects with labyrinthin-positive adenocarcinomas","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388084635","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0632"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0632","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A722.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A722.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077391276","display_name":"Tianhong Li","orcid":"https://orcid.org/0000-0001-7422-3520","observed_orcids":["https://orcid.org/0000-0001-7422-3520"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tianhong Li","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030925628","display_name":"Shuai Chen","orcid":"https://orcid.org/0000-0002-4016-8217","observed_orcids":["https://orcid.org/0000-0002-4016-8217"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuai Chen","raw_affiliation_strings":["University of California, Davis, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis, Sacramento, CA, USA","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006450872","display_name":"Weijie Ma","orcid":"https://orcid.org/0000-0002-4434-1371","observed_orcids":["https://orcid.org/0000-0002-4434-1371"]},"institutions":[{"id":"https://openalex.org/I4390039337","display_name":"Dartmouth Health","ror":"https://ror.org/01pa9ed26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I107672454","https://openalex.org/I4390039337"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weijie Ma","raw_affiliation_strings":["Dartmouth Health, Lebanon, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dartmouth Health, Lebanon, NH, USA","institution_ids":["https://openalex.org/I4390039337"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036407587","display_name":"Kyra A. Toomey","orcid":"https://orcid.org/0000-0002-1758-3527","observed_orcids":["https://orcid.org/0000-0002-1758-3527"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyra A Toomey","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034978579","display_name":"Siqi Long","orcid":"https://orcid.org/0000-0002-3682-2490","observed_orcids":["https://orcid.org/0000-0002-3682-2490"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siqi Long","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082354263","display_name":"Tingting Lu","orcid":"https://orcid.org/0000-0002-3140-5882","observed_orcids":["https://orcid.org/0000-0002-3140-5882","https://orcid.org/0000-0002-0802-8572"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tingting Lu","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103328407","display_name":"Colleen A. Pineda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Pineda","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088140112","display_name":"Laura Molnar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Molnar","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041208390","display_name":"Leslie A Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Garcia","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046103372","display_name":"Kit Wah Tam","orcid":"https://orcid.org/0009-0001-5392-4739","observed_orcids":["https://orcid.org/0009-0001-5392-4739"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kit Tam","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110922010","display_name":"Rashmi Verma","orcid":"https://orcid.org/0000-0001-8136-6933","observed_orcids":["https://orcid.org/0000-0001-8136-6933"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rashmi Verma","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091155896","display_name":"Chihong Zhou","orcid":"https://orcid.org/0000-0003-3249-4095","observed_orcids":["https://orcid.org/0000-0003-3249-4095"]},"institutions":[{"id":"https://openalex.org/I4210160856","display_name":"UC Davis Health","ror":"https://ror.org/05q8kyc69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chihong Zhou","raw_affiliation_strings":["UC Davis Health \u2013 Pathology, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Health \u2013 Pathology, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4210160856"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nancy Ogilhara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Ogilhara","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076543636","display_name":"Michael Babich","orcid":"https://orcid.org/0000-0002-9556-6183","observed_orcids":["https://orcid.org/0000-0002-9556-6183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Babich","raw_affiliation_strings":["LabyRx Immuno-Oncology, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LabyRx Immuno-Oncology, Sacramento, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A722","last_page":"A722"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.061799999326467514,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gm-csf-adjuvant","display_name":"GM-CSF adjuvant","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.878000020980835},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.4970000088214874},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.5339999794960022},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6769999861717224},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6639999747276306},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.421999990940094},{"id":"https://openalex.org/keywords/lung-cancer-biomarkers","display_name":"lung cancer biomarkers","score":0.3019999861717224},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.5740000009536743},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tumor-infiltrating-neutrophils","display_name":"tumor-infiltrating neutrophils","score":0.6779999732971191},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.5659999847412109},{"id":"https://openalex.org/keywords/tumor-infiltrating-b-cells","display_name":"tumor-infiltrating B cells","score":0.6679999828338623},{"id":"https://openalex.org/keywords/tumor-infiltrating-dendritic-cells","display_name":"tumor-infiltrating dendritic cells","score":0.5809999704360962},{"id":"https://openalex.org/keywords/tumor-infiltrating-treg-cells","display_name":"tumor-infiltrating Treg cells","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8427313566207886},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6517674922943115},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6159894466400146},{"id":"https://openalex.org/C2777478134","wikidata":"https://www.wikidata.org/wiki/Q423660","display_name":"Granulocyte macrophage colony-stimulating factor","level":3,"score":0.6139600872993469},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6015092134475708},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5799373984336853},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5499590635299683},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5177758932113647},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4344545006752014},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3805444538593292},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37677428126335144},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36915627121925354},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34380245208740234},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2864726781845093}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0632","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A722.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:78e5d81f339541f5bfb4f5793638c188","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/78e5d81f339541f5bfb4f5793638c188","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0632","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0632","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A722.full.pdf","source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","score":0.75,"display_name":"Zero hunger"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1585092768","display_name":null,"funder_award_id":"NCI P30CA093373","funder_id":"https://openalex.org/F4320337900","funder_display_name":"Comprehensive Cancer Center, University of California, Davis"},{"id":"https://openalex.org/G2075359013","display_name":null,"funder_award_id":"P30CA093373","funder_id":"https://openalex.org/F4320332564","funder_display_name":"University of California, Davis"},{"id":"https://openalex.org/G3035950223","display_name":null,"funder_award_id":"NCI P30 CA093373","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5705938078","display_name":null,"funder_award_id":"NCI P30CA093373","funder_id":"https://openalex.org/F4320332564","funder_display_name":"University of California, Davis"},{"id":"https://openalex.org/G776903742","display_name":null,"funder_award_id":"P30-CA093373","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7938659809","display_name":null,"funder_award_id":"P30CA093373","funder_id":"https://openalex.org/F4320337900","funder_display_name":"Comprehensive Cancer Center, University of California, Davis"}],"funders":[{"id":"https://openalex.org/F4320332564","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337900","display_name":"Comprehensive Cancer Center, University of California, Davis","ror":"https://ror.org/02kcc1z29"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388084635.pdf","grobid_xml":"https://content.openalex.org/works/W4388084635.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2585407512","https://openalex.org/W3037068108","https://openalex.org/W2059423835","https://openalex.org/W2945780494","https://openalex.org/W3041652591","https://openalex.org/W2517747645","https://openalex.org/W2062691140","https://openalex.org/W3114060412","https://openalex.org/W2521234799","https://openalex.org/W2969843676"],"abstract_inverted_index":{"Background":[0],"Adenocarcinomas":[1],"account":[2],"for":[3,416],"more":[4],"than":[5],"70%":[6],"of":[7,22,25,27,181,227,263,283,289,341,353,358,379,468,471,483,486,498],"cancer-related":[8],"deaths.":[9],"Labyrinthin":[10],"(LAB)":[11],"is":[12,51,78,200],"a":[13,52,71,175,368],"novel":[14,53],"tumor-specific":[15],"protein":[16],"expressed":[17],"on":[18,156,161,266,300,318],"the":[19,23,43,88,120,153,203,261,278,281,287,339,348,354,371,406,419,425,436,444,466,469,476,484],"cell":[20,124],"surface":[21],"majority":[24],"adenocarcinomas":[26,45,236,360],"various":[28,267,359],"cancer":[29,47],"types.":[30],"We":[31],"hypothesize":[32],"that":[33,56,95,102],"vaccination":[34],"against":[35,42],"LAB":[36,147,284],"can":[37],"elicit":[38,64],"strong":[39],"immune":[40,90,228,268],"responses":[41,269],"LAB-expressing":[44],"in":[46,111,138,174,186,190,212,338,382],"patients.":[48],"LabVax":[49,84,96,131,182,264,290,315],"3(22)-23":[50,85,97,132,183,265,316],"anti-tumor":[54],"vaccine":[55],"contains":[57],"4":[58],"synthetic":[59],"LAB-based":[60],"peptides":[61],"designed":[62],"to":[63,86,201,274,296,335,375,465],"both":[65],"B-cell":[66],"and":[67,133,168,184,205,244,277,286,306,314,324,326,412,443,473,496],"T-cell":[68],"responses.":[69],"Sargramostim,":[70],"recombinant":[72],"granulocyte":[73],"macrophage":[74],"colony-stimulating":[75],"factor":[76],"(GM-CSF),":[77],"given":[79],"as":[80],"an":[81,393],"immunostimulator":[82],"with":[83,119,143,152,164,188,192,214],"boost":[87],"antitumor":[89],"response.":[91],"Preclinical":[92],"studies":[93],"showed":[94],"significantly":[98],"inhibited":[99],"tumor":[100,302,459],"growth":[101],"was":[103,149,403,462,506],"augmented":[104],"by":[105,210,304,405,424,435,475,508],"GM-CSF":[106,134,185],"without":[107],"any":[108],"significant":[109],"toxicity":[110],"C57/BL6":[112],"transgenic":[113],"mice":[114],"expressing":[115],"human":[116,458],"PD-1/PD-L1":[117],"implanted":[118],"murine":[121],"colon":[122],"adenocarcinoma":[123,158,219],"line":[125,226],"MC-38-huPD-L1.":[126],"In":[127,385],"phase":[128,176,376],"I":[129],"first-in-human":[130],"were":[135],"well":[136],"tolerated":[137],"10":[139],"heavily":[140],"pre-treated":[141],"patients":[142,191,293,391,396],"LAB-expressing,":[144],"refractory":[145,193],"adenocarcinomas.":[146,195],"expression":[148,154,285,299],"positively":[150],"associated":[151],"PD-L1":[155],"lung":[157,218],"(LUAD).":[159],"Based":[160],"preclinical":[162],"synergism":[163],"pembrolizumab,":[165],"this":[166],"dose":[167],"injection":[169],"schedule":[170],"will":[171,361,373,397],"be":[172,362,398],"tested":[173],"II":[177],"open":[178],"label":[179],"study":[180,372,461],"combination":[187],"pembrolizumab":[189,327],"LAB-positive":[194],"Methods":[196],"The":[197,457,503],"primary":[198],"objective":[199,206],"assess":[202],"safety":[204],"response":[207],"rate":[208],"(ORR)":[209],"RECISTv1.1":[211],"participants":[213,357,381],"advanced/metastatic":[215],"or":[216,234,344],"recurrent":[217],"who":[220],"have":[221,297,367],"received":[222],"at":[223],"least":[224],"one":[225],"checkpoint":[229],"inhibitor":[230],"therapy":[231],"(Cohort":[232,237],"A)":[233],"non-lung":[235],"B).":[238],"Secondary":[239],"endpoints":[240],"include":[241],"adverse":[242],"effects":[243],"clinical":[245,504],"laboratory":[246],"abnormalities":[247],"per":[248],"CTCAEv5.0,":[249],"median":[250],"progression-free":[251],"survival":[252],"(PFS),":[253],"6-month":[254],"PFS,":[255],"overall":[256],"survival.":[257],"Exploratory":[258],"objectives":[259],"measure":[260],"effect":[262],"(cytokines,":[270],"anti-LAB":[271],"antibody":[272],"production":[273],"each":[275,383],"peptide)":[276],"correlation":[279],"between":[280],"level":[282],"efficacy":[288],"3(22)-23.":[291],"Eligible":[292],"are":[294],"required":[295],"labyrinthin":[298],"their":[301],"cells":[303],"IHC":[305],"adequate":[307],"organ":[308],"function.":[309],"Patients":[310],"receive":[311],"sargramostim":[312],"subcutaneously":[313],"intradermally":[317],"weeks":[319,333],"1,":[320],"2,":[321],"4,":[322],"8,":[323],"12":[325],"200":[328],"mg":[329],"IV":[330],"every":[331],"3":[332],"up":[334],"17":[336],"treatments":[337],"absence":[340],"disease":[342],"progression":[343],"unacceptable":[345],"toxicity.":[346],"For":[347],"Phase":[349],"2":[350,377],"lead-in":[351],"part":[352],"study,":[355],"6":[356],"enrolled.":[363,399],"If":[364],"\u22642":[365],"subjects":[366],"DLT,":[369],"then":[370],"proceed":[374],"expansions":[378],"18":[380,500],"cohort.":[384],"Cohort":[386],"A,":[387],"if":[388],"\u22652":[389],"LUAD":[390],"respond,":[392],"additional":[394],"25":[395],"Acknowledgements":[400],"This":[401],"research":[402],"supported":[404],"Personalized":[407],"Cancer":[408,429,438,491],"Therapy":[409],"Gift":[410],"Fund":[411],"Novel":[413],"Treatment":[414],"Strat":[415],"Adenocarcinoma":[417],"(T.L.),":[418],"Biostatistics":[420],"Shared":[421],"Resource":[422],"funded":[423],"UC":[426],"Davis":[427,488,490],"Comprehensive":[428],"Center":[430,492],"Support":[431],"Grant":[432],"(CCSG)":[433],"awarded":[434],"National":[437],"Institute":[439],"(NCI":[440],"P30CA093373)":[441],"(S.C.),":[442],"LabyRx":[445],"Immuno-Oncology,":[446],"Sacramento,":[447],"CA.":[448],"Trial":[449],"Registration":[450],"Clinical":[451],"trial":[452,505],"information:":[453],"NCT05101356.":[454],"Ethics":[455,481],"Approval":[456],"specimen":[460],"conducted":[463],"according":[464],"guidelines":[467],"Declaration":[470],"Helsinki":[472],"approved":[474,507],"Institutional":[477],"Review":[478],"Board":[479],"(or":[480],"Committee)":[482],"University":[485],"California,":[487],"(UC":[489],"Biorepository":[493],"Protocol#":[494],"293828,":[495],"date":[497],"approval:":[499],"January":[501],"2012).":[502],"UCD":[509],"IRB.":[510]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}